REG - MyCelx Tech. Corp. MyCelx Tech. Corp.. - Director/PDMR Shareholding
RNS Number : 4270RMyCelx Technologies Corporation04 November 20214 November 2021
Mycelx Technologies Corporation
("Mycelx" or the "Company" (AIM: MYX)
Dealing by Director
The Company announces that it was notified on 4 November 2021 by Hal Alper, President, Chief Science Officer and a Director of the Company, that on 1 November 2021 he sold 20,000 Common Shares at a price of £0.72 per Common Share. Following this transaction, he continues to be interested in 1,242,046 Common Shares representing 6.39 per cent of the present issued capital of the Company and in 124,339 options over the Company's Common Shares.
For further information please contact:
MYCELX Technologies Corporation
Connie Mixon, CEO
Kim Slayton, CFO
Tel: +1 888 306 6843
Canaccord Genuity, Nominated Adviser
Henry Fitzgerald-O'Connor
Georgina McCooke
Tel: + 44 20 7523 8000
Celicourt
Mark Antelme
Jimmy Lea
Tel: +44 20 8434 2754
Notification of transactions of persons discharging managerial responsibility or connected persons
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Hal Alper
2
Reason for the notification
a)
Position/status
Director
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Mycelx Technologies Corporation
b)
LEI
213800UJZINIK2VD1G48
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Common shares of US$0.025
USU624551078
b)
Nature of the transaction
Disposal of Common Shares
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£0.72
20,000
d)
Aggregated information
- Aggregated volume
- Price
n/a
n/a
e)
Date of the transaction
1/11/2021
f)
Place of the transaction
London Stock Exchange
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDDSHFLFVTLSLSIIL
Recent news on Mycelx Technologies
See all newsREG - MyCelx Tech. Corp. MyCelx Tech. Cp-MYXR - Business Update
AnnouncementRCS - MyCelx Tech. Corp. - EPA Publishes National Drinking Water Standards
AnnouncementREG - MyCelx Tech. Corp. MyCelx Tech. Cp-MYXR - Director Dealing
AnnouncementREG - MyCelx Tech. Corp. MyCelx Tech. Cp-MYXR - Director Dealing
AnnouncementREG - MyCelx Tech. Corp. MyCelx Tech. Cp-MYXR - Director Dealing
Announcement